Target intelligence / Profile preview

Extracellular matrix and cell surface adhesion receptors (ECM/CSAR)

Target
ECM/CSAR
Molecular classification
Receptor, Other
01

Overview

The extracellular matrix (ECM) and cell surface adhesion receptors constitute a complex structural and functional network that provides physical support and biochemical signaling cues to cells (Source: Nature Reviews Molecular Cell Biology, "The extracellular matrix at a glance"). This scaffold includes fibrous proteins like collagen and glycoproteins like fibronectin, which serve as ligands for cell surface receptors such as integrins and cadherins (Source: Molecular Biology of the Cell, Alberts et al.). These interactions govern critical biological processes, including cell adhesion, migration, and differentiation. In disease states, such as cancer, the ECM is often remodeled to promote tumor invasion and metastasis, while in fibrotic diseases, excessive ECM deposition leads to organ dysfunction (Source: Journal of Cell Science, "ECM remodeling in health and disease"). Therapeutic interventions often target specific components of this system; for example, monoclonal antibodies like Natalizumab target integrins to treat multiple sclerosis by preventing leukocyte adhesion (Source: FDA Label, Tysabri). Because this entry describes a broad structural context rather than a single protein, it is considered a functional category rather than a discrete molecular target.

Other names
Extracellular matrixCell adhesion moleculesECM proteinsAdhesion receptorsCell-matrix interactome
02

Mechanism of action

Modulation of cell-cell and cell-matrix interactions through the inhibition of specific adhesion receptors or the modification of extracellular matrix components.

03

Biological functions

Cell adhesionSignal transductionStructural supportTissue organizationCell migrationWound healing
04

Disease associations

CancerFibrosisInflammationCardiovascular diseaseAutoimmune disease
05

Safety considerations

Impaired wound healingIncreased risk of infectionBleeding complicationsOff-target effects due to ubiquitous expression
06

Interacting drugs

Natalizumab

5 more in the full profile.

07

Biomarkers

Soluble VCAM-1Circulating fibronectinCollagen degradation products (e.g., C-telopeptide)Integrin expression levels

Beyond the preview

Go deeper on Extracellular matrix and cell surface adhesion receptors (ECM/CSAR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix and cell surface adhesion receptors (ECM/CSAR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call